钆塞酸增强MRI肝胆功能数据对原发性硬化性胆管炎预后预测的价值
本研究回顾性纳入73例原发性硬化性胆管炎患者,评估钆塞酸二钠增强MRI的定性和定量特征对2年内不良事件(肝相关死亡、肝失代偿、静脉曲张出血、自发性细菌性腹膜炎、需肝移植)的预测价值,并与临床评分系统比较。多因素分析显示仅Mayo风险评分(p=0.001)和近端肝外胆管相对强化率(REPD)(p=0.035)显著预测不良事件,REPD<4.64时敏感度70%、特异度63%;ANALI非钆评分>3预测肝移植的敏感度87.5%、特异度74.2%。结论认为REPD可提供有用信息,ANALI评分可纳入MRI报告。
要点
- REPD<4.64可预测PSC患者2年内不良事件,敏感度70%、特异度63%。
- ANALI非钆评分>3预测需肝移植的敏感度87.5%、特异度74.2%。
- ANALI评分可纳入PSC患者MRI报告,REPD测量较难或仅用于药物试验。
关键影像表现/征象
- MRI后2年内26例发生不良事件,8例接受肝移植,6例死亡。
- 多因素分析中仅Mayo风险评分(p=0.001)和REPD(p=0.035)显著预测不良事件。
- 仅ANALI非钆评分(p=0.0003)显著预测肝移植。
诊断标准与关键数值
- REPD<4.64预测不良事件的敏感度70%、特异度63%。
- ANALI非钆评分>3预测肝移植需求的敏感度87.5%、特异度74.2%。
临床应用与阅片要点
- ANALI非钆评分可纳入PSC患者MRI报告以提示肝移植需求。
- REPD测量在常规临床中较困难,可能仅适用于药物试验。
局限性
- 回顾性病例对照设计,样本量73例,可能存在选择偏倚。
- REPD测量在常规临床中较困难,限制其推广应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine if functional information from gadoxetate disodium-enhanced MRI is useful in assessing prognosis in primary sclerosing cholangitis (PSC).
MATERIALS AND METHODS: In this retrospective case-controlled study, 73 patients with PSC and gadoxetate-enhanced MRI were enrolled. Four radiologists independently assessed qualitative and quantitative MRI features. The value of these features in predicting adverse events (liver-related death, hepatic decompensation from grade III/IV hepatic encephalopathy, variceal bleeding, spontaneous bacterial peritonitis as well as need for liver transplantation) within 2 years of MRI were compared with recognized radiological scores as well as clinical scoring systems (Mayo Risk Score, Amsterdam-Oxford model and UK PSC score), using multivariate logistic regression and receiver operating characteristic curve analysis.
RESULTS: The cohort consisted of 42 males and 31 females, with a mean age of 41.9 years. In the 2-year period after MRI, 26 patients had adverse events, 8 had liver transplantation, and 6 died. On multivariate analysis, only Mayo Risk Score (p = 0.001) and relative enhancement of proximal extrahepatic bile ducts (REPD) (p = 0.035) were significant in predicting adverse outcomes. REPD of < 4.64 had 70% sensitivity and 63% specificity in such an event. The only variable that significantly predicted liver transplantation was ANALI non-gadolinium score (p = 0.0003). ANALI score of > 3 had a sensitivity of 87.5% and specificity of 74.2% for predicting the need for liver transplantation.
CONCLUSIONS: Relative enhancement ratio of extrahepatic bile ducts at 20 min after gadoxetate disodium provides useful information in predicting adverse events in PSC patients and is complementary or superior to the currently used clinical scoring systems.
KEY POINTS: Question Can functional hepatic and biliary parameters, obtained from gadoxetate-enhanced MRI, be useful in predicting adverse events in patients with primary sclerosing cholangitis? Findings The relative enhancement of proximal bile ducts (REPD) was useful in predicting adverse events and the need for liver transplantation within 2 years of MRI. Clinical relevance ANALI score predicts need for liver transplantation and may be included in MRI reports of patients with PSC. REPD is more difficult to measure on a routine clinical basis and may only be useful in drug trials.
引用
- Sandrasegaran K, Shah AS, Thompson CP, et al. Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)? Eur Radiol. 2026. PMID: 42363965. doi:10.1007/s00330-026-12710-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。